Chromadex Corp
NASDAQ:CDXC
Net Margin
Chromadex Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Chromadex Corp
NASDAQ:CDXC
|
598.5m USD |
9%
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD |
10%
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
181.9B USD |
15%
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
147.6B USD |
14%
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW |
26%
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
40.4B CHF |
10%
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
285.5B CNY |
27%
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.8B USD |
18%
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
33.7B USD |
9%
|
|
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.4B USD |
22%
|
|
| IN |
|
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1.8T INR |
24%
|
Chromadex Corp
Glance View
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Chromadex Corp's most recent financial statements, the company has Net Margin of 8.6%.
You don't have any saved screeners yet